QIAGEN Supports World TB Day — March 24, 2018

QuantiFERON-TB Gold Plus (QFT-Plus) is the leader in innovation in TB testing for improved patient healthcare

It’s time to replace the 100-year old TB skin test. Embrace certainty with QFT-Plus:

  • Single visit blood testing – ensures test completion and provides convenience to your patients – no second visit required
  • Improved testing outcomes – reduced false positives due to BCG vaccinations
  • CD8 technology – for a comprehensive view of the immune response to aid in clinical decision making
  • Objective and measurable results – eliminate subjectivity of PPD placement and induration reading with an easy to administer blood test


The US CDC is changing TB technical instructions for civil surgeons

US Department of Health and Human Services informed US Civil Surgeons that the CDC is changing the TB technical instructions and will no longer be accepting tuberculin skin test (TST) for immigration screening as of October 1, 2018.

International Panel Physician Association endorses QFT-Plus for immigration

IPPA said it “endorses QFT-Plus, which is an FDA-approved IGRA that has been rigorously studied and validated by independent peer reviewed journals.”

New WHO guidelines for Latent TB Testing

The World Health organization recently released new guidelines expanding the groups being prioritized for latent TB testing and now include IGRA tests like QFT-Plus for latent TB testing.

Learn more about the QFT-Plus TB Blood Test

Learn more through our animated videos.

Next generation TB testing with QuantiFERON-TB Gold Plus
Eradicating TB from the modern world

QIAGEN World TB Day Events

Find out more about our regional educational events

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

Get in touch with QIAGEN
Follow QIAGEN on: